MEDWATCH - THE NEW FDA MEDICAL PRODUCTS REPORTING PROGRAM

被引:9
作者
KESSLER, DA
机构
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1993年 / 50卷 / 06期
关键词
D O I
10.1093/ajhp/50.6.1151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1151 / 1152
页数:2
相关论文
共 15 条
[1]  
BOLGER GR, 1992, CONSULT PHARM, V7, P28
[2]  
GELB LN, 1992, FDA MED B, V22, P2
[3]  
GELB LN, 1992, FDA MED B, V22, P3
[4]  
GELB LN, 1993, FDA MED B, V23, P2
[5]  
GELB LN, 1992, FDA MED B, V22, P4
[6]  
JOHNSON JM, 1991, FOOD DRUG LAW J, V46, P665
[7]   USE OF A DATABASE COMPUTER-PROGRAM TO IDENTIFY TRENDS IN REPORTING OF ADVERSE DRUG-REACTIONS [J].
JOHNSTON, PE ;
MORROW, JD ;
BRANCH, RA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (06) :1321-1327
[8]  
KENNEDY DL, 1991, JAMA-J AM MED ASSOC, V266, P2878
[9]   USE OF STANDARDIZED SCREENING PROCEDURES TO IDENTIFY ADVERSE DRUG-REACTIONS [J].
KOCH, KE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (06) :1314-1320
[10]  
Nightingale S L, 1990, JAMA, V264, P2863